Skip to main content
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1996 Sep;105(3):416–421. doi: 10.1046/j.1365-2249.1996.d01-791.x

T cell responses to a mixture of Mycobacterium tuberculosis peptides with complementary HLA-DR binding profiles

S JURCEVIC *, A HILLS *, G PASVOL *, R N DAVIDSON *, J IVANYI *, R J WILKINSON *
PMCID: PMC2200523  PMID: 8809128

Abstract

The T cell response to a mixture of eight peptides derived from sequences of the Mycobacterium tuberculosis 16-, 19- and 38-kD antigens (MTBmix-8) has been studied. The peptides were selected on the basis of complementary binding to nine HLA-DR molecules (HLA-DR1 to DR9). MTBmix-8 at 6.25 and 50 μg/ml gave rise to significant stimulation (P< 0.05) of peripheral blood mononuclear cells (PBMC) from healthy tuberculin-positive and both untreated and treated diseased subjects, but not in any of a control group of healthy tuberculin-negative subjects. MTB-mix-8 stimulated proliferation of PBMC from healthy tuberculin-positive individuals at lower concentrations than the individual component peptides. However, the maximal stimulation achieved was only slightly higher than that achieved with individual peptides. MTBmix-8 also stimulated the production of interferon-gamma (IFN-γ) in vitro. Using the mean ± 2 s.d. of the values for IFN-γ production in the tuberculin-negative population as a cut-off, MTBmix-8 at 6.25 μg/ml was able to detect infection with a sensitivity of 100% in untreated patients, 87% in treated patients, and 82% in tuberculin-positive controls. The corresponding figures for the most potent single peptide (16p91–110) were: 66% in untreated patients, 71% in treated patients and only 42% in controls. Thus, using the IFN-γ-based assay, which has the additional advantages of speed and does not require radioactivity, the mixture of peptides is more sensitive than single peptides in diagnosing infection.

Keywords: Mycobacterium tuberculosis, T cells, peptide, HLA-DR, interferon-gamma

Full Text

The Full Text of this article is available as a PDF (500.7 KB).


Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES